• Home
  • News
  • Personal Finance
    • Savings
    • Banking
    • Mortgage
    • Retirement
    • Taxes
    • Wealth
  • Make Money
  • Budgeting
  • Burrow
  • Investing
  • Credit Cards
  • Loans

Subscribe to Updates

Get the latest finance news and updates directly to your inbox.

Top News

The Great Wealth Transfer’s Hidden Housing Problem

January 20, 2026

Afraid You Won’t Be Able to Afford to Retire? These 10 States Are Your Best Bet

January 20, 2026

Workers Brace for Uncertainty, Prioritize Stability in 2026

January 20, 2026
Facebook Twitter Instagram
Trending
  • The Great Wealth Transfer’s Hidden Housing Problem
  • Afraid You Won’t Be Able to Afford to Retire? These 10 States Are Your Best Bet
  • Workers Brace for Uncertainty, Prioritize Stability in 2026
  • The Main Reason Not To Retire
  • How to Make Your Money Last Decades Longer (Without Getting a Job)
  • These Jobs Pay Six Figures in 2026 — and It’s Relatively Easy to Land One
  • Why Experts Hate Trump’s New 401(k) Homebuying Plan
  • 5 Legit Side Hustles for Introverts (No Uber Driving Required)
Tuesday, January 20
Facebook Twitter Instagram
FintechoPro
Subscribe For Alerts
  • Home
  • News
  • Personal Finance
    • Savings
    • Banking
    • Mortgage
    • Retirement
    • Taxes
    • Wealth
  • Make Money
  • Budgeting
  • Burrow
  • Investing
  • Credit Cards
  • Loans
FintechoPro
Home » ADRs End Mostly Higher, Missfresh and Mesoblast Trade Actively
Investing

ADRs End Mostly Higher, Missfresh and Mesoblast Trade Actively

News RoomBy News RoomAugust 7, 20231 Views0
Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Email Tumblr Telegram

By Denny Jacob

International stocks trading in New York closed mostly higher on Friday.

The S&P/BNY Mellon index of American depositary receipts edged up 0.2% to 156.41. The European index ticked up 0.1% to 149.96. The Asian index climbed 0.3% to 183.83. The Latin American index slipped 0.7% to 202.40, while the emerging-markets index was flat at 303.65.

Missfresh was among those whose ADRs traded actively.

The Chinese online grocery company soared 285% after it reported share-purchase agreements with two investors, an acquisition and the filing of its delayed 2022 annual report.

Mesoblast tumbled 59% after the Food and Drug Administration once again turned away the company’s remestemcel-L drug candidate for children with a potentially life-threatening bone marrow transplant complication, calling on the company to provide more data.

Write to Denny Jacob at [email protected]

Read the full article here

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Related Articles

Even Time-Strapped Business Owners Can Share an Engaging Reading Experience with Their Kids

Investing September 20, 2025

Turnover Is Costing You More Than You Think — Here’s the Fix

Investing September 19, 2025

How Pana Food Truck Started Selling Arepas

Investing September 18, 2025

Amazon CEO Andy Jassy Is Fighting Against Bureaucracy

Investing September 17, 2025

Here Are the Top 50 Mistakes I’ve Seen Kill New Companies

Investing September 16, 2025

Google Parent Alphabet Reaches $3T Market Cap

Investing September 15, 2025
Add A Comment

Leave A Reply Cancel Reply

Demo
Top News

Afraid You Won’t Be Able to Afford to Retire? These 10 States Are Your Best Bet

January 20, 20262 Views

Workers Brace for Uncertainty, Prioritize Stability in 2026

January 20, 20261 Views

The Main Reason Not To Retire

January 19, 20261 Views

How to Make Your Money Last Decades Longer (Without Getting a Job)

January 19, 20262 Views
Don't Miss

These Jobs Pay Six Figures in 2026 — and It’s Relatively Easy to Land One

By News RoomJanuary 19, 2026

ETAP / Shutterstock.comThe race for high-paying jobs is shifting in ways that might surprise you.…

Why Experts Hate Trump’s New 401(k) Homebuying Plan

January 18, 2026

5 Legit Side Hustles for Introverts (No Uber Driving Required)

January 18, 2026

7 Things Nearly Everybody Gets Wrong About Heating Their Homes

January 17, 2026
Facebook Twitter Instagram Pinterest Dribbble
  • Privacy Policy
  • Terms of use
  • Press Release
  • Advertise
  • Contact
© 2026 FintechoPro. All Rights Reserved.

Type above and press Enter to search. Press Esc to cancel.